Evaluating the Effects of Glucagon-Like Peptide 1 Receptor Agonists as a Secondary Prevention in Peripheral Arterial Disease: A Meta-Analysis
In this meta-analysis of randomized trials, GLP-1 RAs were not associated with statistically significant differences in revascularization or amputation outcomes in individuals with diabetes and PAD.
Authors
- MARTIN B. WHYTE
- Ellie Tomlinson
- Christian Heiß (ORCID: https://orcid.org/0000-0002-3212-8995)
- Adrian Hugh Heald (ORCID: https://orcid.org/0000-0002-9537-4050)
- Nirali Desai
- Benjamin C. Field
- Beth Elliott
Institutions
- University of Surrey (GB)
- Salford Royal Hospital (GB)
- King's College Hospital (GB)
Publication Details
- Journal
- Diabetes Therapy
- Published
- 2026-02-16
- DOI
- https://doi.org/10.1007/s13300-026-01843-x
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Surrey